Newsroom

Sorted by: Latest

-

大塚メディカルデバイス/大塚製薬:Paradise 超音波式腎デナベーションシステム 治療抵抗性高血圧症を適応症に保険適用、販売開始

東京--(BUSINESS WIRE)--(ビジネスワイヤ) -- 大塚メディカルデバイス株式会社(本社:東京都、代表取締役社長:東條紀子、以下「大塚メディカルデバイス」)および大塚製薬株式会社(本社:東京都、代表取締役社長:井上眞、以下「大塚製薬」)は、治療抵抗性高血圧症を適応症とする大塚メディカルデバイスの医療機器「Paradise™ 超音波式腎デナベーションシステム (Paradise システム)」が、3月1日に保険適用されたことをお知らせします。これに伴い、大塚メディカルデバイスは、3月2日よりParadise システムの販売を開始し、大塚製薬と共同プロモーションを行います。 Paradise システムは、大塚メディカルデバイスの米国子会社であるRecor Medical, Inc.(以下「Recor Medical」)が開発した医療機器です。本システムは、利尿薬を含むクラスの異なる3剤を使用しても血圧が目標値まで下がらない治療抵抗性高血圧症の患者さんを対象としています。腎交感神経の過活動を抑制することで血圧降下を目指す新たな治療法である超音波式腎デナベーションを、国内で初め...
-

Otsuka Medical Devices/Otsuka Pharmaceutical: Paradise Ultrasound Renal Denervation System for the Treatment of Resistant Hypertension, Now Covered by Insurance and Commercially Available in Japan

TOKYO--(BUSINESS WIRE)--Otsuka Medical Devices Co., Ltd. (Otsuka Medical Devices) and Otsuka Pharmaceutical Co., Ltd. (Otsuka Pharmaceutical) announce that the Paradise™ Ultrasound Renal Denervation (uRDN) system is covered by National Health Insurance system in Japan, effective March 1. Following the inception of insurance coverage, Otsuka Medical Devices has commenced sales of the system on March 2 and will conduct co-promotion with Otsuka Pharmaceutical. The Paradise uRDN system was develope...
-

Lenovo Unveils Adaptive AI PCs, Modular Concepts, and Lenovo Qira Rollout at MWC 2026

BARCELONA, Spain--(BUSINESS WIRE)--At MWC® 2026, Lenovo™ introduces a new generation of adaptive AI devices and forward-looking concepts designed for business professionals, creators, students, and gamers. Headlined by new modular PC architecture, a glasses-free 3D laptop concept, a foldable gaming handheld device, and the initial rollout of Lenovo Qira, Lenovo’s showcase reflects a broader shift in personal computing toward systems that adapt intelligently to people and their environments. Acr...
-

GLXY Investors Have Opportunity to Join Galaxy Digital Fraud Investigation with the Schall Law Firm

LOS ANGELES--(BUSINESS WIRE)--GLXY Investors Have Opportunity to Join Galaxy Digital Fraud Investigation with the Schall Law Firm...
-

VRNS Deadline: Rosen Law Firm Urges Varonis Systems, Inc. (NASDAQ: VRNS) Stockholders to Contact the Firm for Information About Their Rights

NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, reminds investors about a class action lawsuit on behalf of purchasers of common stock of Varonis Systems, Inc. (NASDAQ: VRNS) between February 4, 2025 and October 28, 2025, both dates inclusive (the “Class Period”). Varonis is a global security company. For more information, submit a form, email attorney Phillip Kim, or give us a call at 866-767-3653. The Allegations: Rosen Law Firm is Investigating the Allegations t...
-

RMBS Investors Have Opportunity to Join Rambus Inc. Fraud Investigation with the Schall Law Firm

LOS ANGELES--(BUSINESS WIRE)--RMBS Investors Have Opportunity to Join Rambus Inc. Fraud Investigation with the Schall Law Firm...
-

TSAT Investors Have Opportunity to Join Telesat Corporation Fraud Investigation with the Schall Law Firm

LOS ANGELES--(BUSINESS WIRE)--TSAT Investors Have Opportunity to Join Telesat Corporation Fraud Investigation with the Schall Law Firm...
-

DRVN Investors Have Opportunity to Join Driven Brands Holdings Inc. Fraud Investigation with the Schall Law Firm

LOS ANGELES--(BUSINESS WIRE)--DRVN Investors Have Opportunity to Join Driven Brands Holdings Inc. Fraud Investigation with the Schall Law Firm...
-

IT Investors Have Opportunity to Join Gartner, Inc. Fraud Investigation with the Schall Law Firm

LOS ANGELES--(BUSINESS WIRE)--IT Investors Have Opportunity to Join Gartner, Inc. Fraud Investigation with the Schall Law Firm...
-

TNC Investors Have Opportunity to Join Tennant Company Fraud Investigation with the Schall Law Firm

LOS ANGELES--(BUSINESS WIRE)--TNC Investors Have Opportunity to Join Tennant Company Fraud Investigation with the Schall Law Firm...